Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
PLoS One. 2011;6(11):e26174. doi: 10.1371/journal.pone.0026174. Epub 2011 Nov 3.
Scintillation camera imaging is used for treatment planning and post-treatment dosimetry in liver radioembolization (RE). In yttrium-90 (90Y) RE, scintigraphic images of technetium-99m (99mTc) are used for treatment planning, while 90Y Bremsstrahlung images are used for post-treatment dosimetry. In holmium-166 (166Ho) RE, scintigraphic images of 166Ho can be used for both treatment planning and post-treatment dosimetry. The aim of this study is to quantitatively evaluate and compare the imaging characteristics of these three isotopes, in order that imaging protocols can be optimized and RE studies with varying isotopes can be compared.
METHODOLOGY/PRINCIPAL FINDINGS: Phantom experiments were performed in line with NEMA guidelines to assess the spatial resolution, sensitivity, count rate linearity, and contrast recovery of 99mTc, 90Y and 166Ho. In addition, Monte Carlo simulations were performed to obtain detailed information about the history of detected photons. The results showed that the use of a broad energy window and the high-energy collimator gave optimal combination of sensitivity, spatial resolution, and primary photon fraction for 90Y Bremsstrahlung imaging, although differences with the medium-energy collimator were small. For 166Ho, the high-energy collimator also slightly outperformed the medium-energy collimator. In comparison with 99mTc, the image quality of both 90Y and 166Ho is degraded by a lower spatial resolution, a lower sensitivity, and larger scatter and collimator penetration fractions.
CONCLUSIONS/SIGNIFICANCE: The quantitative evaluation of the scintillation camera characteristics presented in this study helps to optimize acquisition parameters and supports future analysis of clinical comparisons between RE studies.
闪烁相机成像用于肝脏放射性栓塞治疗(RE)的治疗计划和治疗后剂量测定。在钇-90(90Y)RE 中,锝-99m(99mTc)闪烁显像用于治疗计划,而 90Y 韧致辐射成像用于治疗后剂量测定。在钬-166(166Ho)RE 中,166Ho 的闪烁显像可用于治疗计划和治疗后剂量测定。本研究的目的是定量评估和比较这三种同位素的成像特性,以便优化成像方案,并比较不同同位素的 RE 研究。
方法/主要发现:根据 NEMA 指南进行了体模实验,以评估 99mTc、90Y 和 166Ho 的空间分辨率、灵敏度、计数率线性和对比度恢复。此外,还进行了蒙特卡罗模拟,以获取有关检测光子历史的详细信息。结果表明,对于 90Y 韧致辐射成像,使用宽能窗和高能准直器可获得灵敏度、空间分辨率和初级光子分数的最佳组合,尽管与中能准直器的差异较小。对于 166Ho,高能准直器也略微优于中能准直器。与 99mTc 相比,90Y 和 166Ho 的图像质量因空间分辨率较低、灵敏度较低以及散射和准直器穿透分数较大而降低。
结论/意义:本研究对闪烁相机特性的定量评估有助于优化采集参数,并支持未来对 RE 研究中临床比较的分析。